Market Tracker

06/24 5:16pm ET

Perrigo Company PLC (NYSE:PRGO)

91.01
Delayed Data
As of Jun 24
 -4.19 / -4.40%
Today’s Change
84.85
Today|||52-Week Range
198.42
-37.10%
Year-to-Date
Valeant Enlists Former Tyco Exec for More Help With Accounting
Jun 22 / TheStreet.com - Paid Partner Content
Perrigo Sells Vitamins Business to IVC
Jun 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close95.20
Today’s open91.53
Day’s range90.94 - 94.08
Volume3,016,164
Average volume (3 months)2,717,958
Market cap$13.6B
Dividend yield0.64%
Data as of 4:04pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)+36.36%
P/E ratio19.2
Price/Sales3.82
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-6.64-7.94%
INCYIncyte Corp-4.68-5.73%
MDVNMedivation Inc-2.31-3.90%
JAZZJazz Pharmaceuticals...-7.10-4.90%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 31, 2016
EPS forecast (this quarter)$2.00
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer &
Executive Vice President
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts